ムηδï ҝÛrŋïДщªŋ™

[Bio Protocol @BioProtocol]

What if the next breakthrough in longevity, fertility, or neuroscience didn't start in a closed lab or a private pitch deck?

What if it started as a public post. One anyone could vote on, collaborate on, and fund.

[CZ 🔶 BNB @cz_binance]

Our kids will judge us on how we regulate and progress AI and crypto innovations today.

[Bio Protocol @BioProtocol]

May in the Biosphere 🌐

- PeptAI Ignition Sale: 32x+ oversubscribed, 1.6M+ USDC committed by 1.4K+ participants. veBIO staker reward claims now live in the Bio app. Next: first on-chain wet-lab attestation via Molecule Labs in Q2.

- BIO on Robinhood: $BIO is now tradable on @RobinhoodApp, bringing DeSci to one of the world's most widely used retail trading platforms.

- BIOS Live Demo: Upcoming features include new biotech tool integrations, image segmentation, and an in-house robotics program to close the full autonomous loop from receptor to wet-lab result.

Read the full monthly report ↓

[Paul Kohlhaas bio/acc @paulkhls]

We’re about to release an incredible upgrade

The scientific singularity begins when an infinite number of hypotheses on everything become feasible, and fundable

[Bio Protocol @BioProtocol]

Science has never been short on good ideas.

The real bottleneck has always been everything that comes after the idea.

You still need funding, the right data, and lab time, and each of those steps comes with its own friction and delays.

For funding, you need to wait for committee reviews. The specific dataset you need is often locked away by whoever controls it. Booking equipment usually means chasing the right person just to get it set up.

Months can pass by before anything meaningful actually happens.

Now agents are starting to break through those barriers.

They can hold a budget and spend it as soon as it’s needed. Pull the data, secure the lab time, run the experiment, and immediately use the results to plan the next step.

The whole loop is finally starting to move on its own.

[Paul Kohlhaas bio/acc @paulkhls]

If you're in crypto pivot to biotech

[Omega @omegapexi]

Peptai lansmanı ATH seviyesinde 26x yaptı. Puanlarla alınan alloclar, eski stakerların maliyetini çıkardı. Üstüne gelen airdrop ödülleri de güzel bir bonus oldu.

Yeni lansman Alive ise 4 gün sonra geliyor. Eğer projeler hızlı şekilde launch olmaya ve stakerlara düzenli ödül dağıtılmaya devam ederse, Bionun yeni lansman modeli eskisine kıyasla çok daha başarılı olabilir.

Ayrıca $PEPTAI tarafında yeni haberler de yolda. Takip etmekte fayda var.

@BioProtocol

[Paul Kohlhaas bio/acc @paulkhls]

Ever felt like kissing a rocket? 💋🚀

1/ 🧵 2 weeks ago we stealth dropped: KISS1R-report-v1.2.pdf the latest insilico results from @peptai_

We took natural kisspeptin-10 (KP-10) and used our autonomous AI pipeline to design two ncAA-modified agonists, C1-01 and C1-02, that hit KISS1R (GPR54) with dramatically better potency and stability

This is the master regulator of the entire reproductive axis. Here’s why it matters 👇

[MRCY🐾 @Thismrcy11]

I know everyone’s eyes are glued to the PeptAI Ignition Sale on Bio launchpad right now, and for good reasons.

It hit 100% of the 50K USDC goal in no time, now sitting at a crazy 16.4X oversubscription with over 822K USDC and 590M+ BioXP contributed.

But while the sale is popping off, a lot of us are not paying attention to something equally bigger that’s already live and shipping: BIOS.

BIOS (https://t.co/T7tZTDZvZl) is Bio Protocol’s autonomous AI Scientist which is your personal research assistant for complex biomedical questions.

It was launched late January 2026 and has quickly become one of the most advanced tools in DeSci.

What it does:
• Orchestrates Literature + Data Analysis agents that actually read papers, refine hypotheses, run Python code, and build persistent memory across sessions

• Modes from Steering (you control every step) to Autonomous Deep (runs for hours)

• Currently #1 on BixBench with 48.78% accuracy beating much bigger models In the screenshot you can see it greeting you and listing everything it can help with:

experiment planning, evidence synthesis, mechanism understanding, clinical trials, drug development, longevity research… basically anything in life sciences.

This is the real agentic science layer powering tools like PeptAI. While the sale funds the next breakthroughs,

BIOS is the engine actually doing the science right now.

If you’re into DeSci, don’t just partake in the sale, go try BIOS too (free for .edu emails in early access).

Still a few days to participate in the @peptai_ sale: pledge your BioXP + USDC on the launchpad before it closes. @BioProtocol

[Evelyn Farmer @evelyn_far9754]

$ROSE Here we go https://t.co/OPaa1wGCrg

[Molecule @Molecule_sci]

Recently @Bankless did a piece on where DeSci goes next as AI collapses the cost of drug discovery. Molecule Labs is called out as the open data layer that the ecosystem has been missing.

The argument from @davewardonline: drug development has always been gated at the earliest stage by capital, not by science. When discovery costs collapse, a research collective can fund a candidate all the way to real lab data. That opens up categories of research pharma was never going to touch.

The biology behind ADHD's orexin system has been documented for years, but no institution with the capital has spent time developing it. An AI scientist called @peptai_ did, in roughly 24 hours.

@peptai_ is using Molecule Labs to manage the work. Every research program's data, IP, and treasury lives in one place, openly tracked. Milestones, results, and failed experiments stay on the record. Future researchers and AI agents build on the work.

[OGAntD @0GAntD]

Bio Protocol is really gonna launch PeptAI at the perfect time

Market is getting more risk on, AI and Peptide/Healthcare stocks absolutely ripping, people just waiting to buy something good/speculate on these sectors in crypto

Convicted we can see a mini Virtuals type run here

[CllayBaba @Cllaytus]

- @OasisProtocol announced its latest community update video, introducing FlexVaults: a system storing private keys in confidential TEE enclaves with a programmable policy engine for transaction signing while keeping assets on native chains.

- Key advantages emphasized include no bridges, no custodians, and no exposed keys, enabling secure, verifiable privacy for applications like AI agents that require controlled asset access without full key exposure.

- The update also recaps recent developments with projects including MidasRWA, Contexto, Teepin, and Diode Chain plus EthCC highlights, as the first FlexVaults use case was slated for release the same day.

This clip is a snippet on EthCC. Full video here: https://t.co/FJAZTVRaaA

[MRCY🐾 @Thismrcy11]

DeSci enthusiasts/scientists,

I noticed so many people on CT finally catching on to what @BioProtocol has been building for years now, especially with the $PEPTAI Ignition Sale going parabolic.

But for those who just onboarded or are still sitting on the fence, let me break it all down properly

What is Bio Protocol?

Bio protocol is DeSci’s premier financial and infrastructure layer.

It lets communities fund, launch, govern, and commercialize scientific research onchain through BioDAOs and tokenized IP.

Staking $BIO gives you passive exposure via airdrops, priority in sales, and meta governance across the ecosystem.

~The Journey So Far Roots back to https://t.co/7Dgj6sMesr and the launch of @vitadao in 2021, one of the first major BioDAOs focused on longevity.

Fast forward: BIO token genesis in 2024/2025 raised strong capital (Binance Labs’ first DeSci bet + others like 1kx).

Then by 2026, the ecosystem has delivered $50M+ in research funding, $65M+ in BioDAO treasuries, and hundreds of millions in combined market cap.

~The BioDAO EcosystemKey players include:

- @vitadao, Longevity pioneer (Pfizer Ventures backed)

- @Cerebrum_DAO, Brain health

- @valley_dao, Synthetic biology & climate

- @D1ckDAO, Men's health

- @athenabiorg

- @psy_dao

- @cryodao and more

These aren’t just funding groups, they’re consistently bridging science with university partners and IP tokens.

~The AI Leap(my favorite part)

This Changes Everything as Bio Protocol didn’t stop at funding. They built the BioAgent open source framework and launched serious AI scientist BIOS

The core AI Scientist for literature review, hypothesis generation, and research orchestration.

This agents synthesize knowledge and accelerate real discovery 100%.

~Now, $PEPTAI...the Current Moment.
Everyone is watching...👀

A fleet of autonomous AI agents specialized in peptide drug discovery.

Each agent targets one receptor (GLP-1R for metabolic health, KISS1R for fertility, OX2R for ADHD + community-chosen).

They design candidates, run full 9-gate computational validation, and push promising ones to wet labs via @adaptyvbio with onchain payments and attestations.

@peptai_ famously designed a novel ADHD peptide candidate in ~24 hours for ~$1,500 wet-lab validation cost.

This is AI agents moving from trading memes to entering the wet lab.

The Ignition Sale...$50k raise at $1M FDV is already heavily oversubscribed (~12.5)

> 5% via sale (USDC)
> 20% airdrop to $BIO stakers
~The Journey So Far Roots go back to cation (earn via staking or mint with $BIO)

This small raise is showing massive demand for real AI + science execution.

Last year DeSci felt niche but it's different now
That is motion...more to come!

[Alex M @a_miloski]

Been a long building season at @vitadao. a few updates:

1/ VitaApp is in private alpha. selected community members being served first, public release follows shortly. this will be the first VitaDAO consumer app, with our own longevity AI engine built in @Aubrai_ . health optimization grounded in research; encrypted end to end to preserve users privacy - finally an app like this will come into existence.

2/ Aubrai is our AI agent built to accelerate the science itself. generates hypotheses, sends them to CROs for validation, pays scientists when results land. closing a native AI-to-wet-lab integration soon.

3/ VitaRNA, one of our first IPT projects, is developing tRNA suppressor gene therapies for nonsense mutations tied to aging. led by Michael Torres, who just recently sold his last biotech company to Eli Lilly in a deal worth up to $300M. VitaRNA was funded with $91K from vitadao + $300K via IPT sale, partnered with Lonza for GMP manufacturing. lead candidate ARTAN-102 just showed 350x liver expression in vivo. next stop: primate toxicity.

4/ the portfolio is moving too: Gero (backed in 2023) signed Roche's Chugai in July 2025. up to ~$250M in milestones, 1B+ potential with royalties, for AI-discovered antibody targets in age-related disease. platform trained on 100M+ longitudinal medical records.

5/ Rubedo (backed in 2021) is also making progress on AI. their ALEMBIC platform reads single-cell data from primary human tissue to find pathologic senescent cells. SenTech then designs the molecule against them. result: RLS-1496, the first GPX4 modulator ever dosed in humans (May 2025). positive Phase 1 readouts in psoriasis, atopic dermatitis and photo-aged skin came in March 2026. Phase 2a coming.

6/ and we're rebuilding VitaLabs, VitaDAO's incubation program into a fully AI-native longevity biotech venture studio. tiny founding teams, $100-150K, 6-9-month proof factories with CROs and pharma BD pre-wired from day one. cohort 1 capped at 3 projects. whitepaper out soon.

Crypto compounds capital, AI compounds intelligence and biotech compounds biology. we're building where the three meet.

[余烬 @EmberCN]

Bio Protocol 在最近两天里上线了质押 $BIO 打新， $BIO 在最近两天里上涨了 100%。

而在 $BIO 快速上涨后，Bio Protocol 多签钱包在 8 小时前把 8000 万枚 $BIO ($515 万) 转进了 Binance 和 OKX。

这是借利好出货吗？

地址：https://t.co/mZ4SFGhCTi

----------------------------------------------------
#Bitget VIP 费率更低，福利更狠！买美股秒级入场

[Erhan Ünal @erhanunal]

Boğa sezonunun tartışmasız en büyük metası DeSci kategorisi yani $BIO olacak. Market büyüklüğü şimdilik 109 milyon dolar.
@peptai_ sonrası neden 5 milyar dolar olmasın? Ben sebep göremiyorum!

[CZ 🔶️ BNB - Parody @czbinanceprd]

BTC will rally to $200,000 - $300,000 this year.

Bookmark it!